Injectable codeine is accessible for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this can lead to nonimmune mast-mobile degranulation and resulting anaphylactoid response. Codeine suppositories can also be promoted in a few nations around the world. In Eire, new rules came into effect on one August 2010[ninety] https://www.codeingil.com/